Fairvalue-Calculator Fairvalue-Calculator
EN DE

Novolog (Pharm-Up 1966) Ltd (NVLG) Fair Value & Analysis

Healthcare · Il · Market cap 413M ILA

Price0.7640 ILA
Fair Value0.5500 ILA
Upside-28.0%
Quality94/100
Evidence: High Range 0.3500 ILA – 0.7500 ILA

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Novolog (Pharm-Up 1966) Ltd (NVLG) currently trades at 0.7640 ILA, while our model-based Fair Value estimate is 0.5500 ILA — implying the stock looks roughly 28.0% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and diagnostic laboratory, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division identifies and develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics, doctors therapists, and medical bodies; provides services and management tools; and operates and markets digital…

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) -80% Cencora, Inc (C1CO34) -89% Cardinal Health, Inc (CAH) -36% Sigma Healthcare Limited (SIGGF) -73% Sitka Gold Corp (SIG) -59% Shanghai Pharmaceuticals Holding (601607) +183%

Frequently asked questions

Is Novolog (Pharm-Up 1966) Ltd (NVLG) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 0.5500 ILA versus a price of 0.7640 ILA — about −28% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NVLG?
Our 21-model fair value for Novolog (Pharm-Up 1966) Ltd is 0.5500 ILA (as of Jun 24, 2026), built from audited fundamentals. The current price is 0.7640 ILA.
What is the quality score of NVLG?
Novolog (Pharm-Up 1966) Ltd has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.